Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer	Neoadjuvant Non-Small Cell Lung Cancer	Not yet recruiting	Phase 2	2024-11-12		NCT06682884

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Air Force Military Medical University, China	39
Hunan Cancer Hospital	66
Liaoning Cancer Hospital & Institute	53
Peking University People's Hospital	269
Second Affiliated Hospital, Zhejiang University, School of Medicine	561

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials